1. Home
  2. CLLS vs CTGO Comparison

CLLS vs CTGO Comparison

Compare CLLS & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • CTGO
  • Stock Information
  • Founded
  • CLLS 1999
  • CTGO 2009
  • Country
  • CLLS France
  • CTGO United States
  • Employees
  • CLLS N/A
  • CTGO N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • CLLS Health Care
  • CTGO Basic Materials
  • Exchange
  • CLLS Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • CLLS 299.0M
  • CTGO 268.0M
  • IPO Year
  • CLLS 2007
  • CTGO N/A
  • Fundamental
  • Price
  • CLLS $3.08
  • CTGO $23.65
  • Analyst Decision
  • CLLS Buy
  • CTGO Strong Buy
  • Analyst Count
  • CLLS 1
  • CTGO 1
  • Target Price
  • CLLS $4.00
  • CTGO $37.00
  • AVG Volume (30 Days)
  • CLLS 71.4K
  • CTGO 94.5K
  • Earning Date
  • CLLS 11-03-2025
  • CTGO 11-13-2025
  • Dividend Yield
  • CLLS N/A
  • CTGO N/A
  • EPS Growth
  • CLLS N/A
  • CTGO N/A
  • EPS
  • CLLS N/A
  • CTGO N/A
  • Revenue
  • CLLS $63,438,000.00
  • CTGO N/A
  • Revenue This Year
  • CLLS N/A
  • CTGO N/A
  • Revenue Next Year
  • CLLS $66.76
  • CTGO N/A
  • P/E Ratio
  • CLLS N/A
  • CTGO N/A
  • Revenue Growth
  • CLLS 223.09
  • CTGO N/A
  • 52 Week Low
  • CLLS $1.10
  • CTGO $8.85
  • 52 Week High
  • CLLS $3.35
  • CTGO $24.70
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 62.30
  • CTGO 62.42
  • Support Level
  • CLLS $2.88
  • CTGO $21.26
  • Resistance Level
  • CLLS $3.20
  • CTGO $22.33
  • Average True Range (ATR)
  • CLLS 0.17
  • CTGO 1.02
  • MACD
  • CLLS 0.02
  • CTGO 0.17
  • Stochastic Oscillator
  • CLLS 68.24
  • CTGO 73.21

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

Share on Social Networks: